B
BIIB
BIIBUnverified28 segments tracked|10 years of data|Annual (10-K)
Total Revenue
$17.0B0.7%
FY2025
Operating Segments
28Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%MSProduct Revenues
Segment Shift
MSProduct Revenues has grown from 0.0% to 23.8% of total revenue since FY2014, with 0.0% operating margins. Meanwhile, Alzheimers Collaboration is the fastest growing at +196.7% YoY.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2025
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| MSProduct Revenues | $4.0B | $0 | 0.0% | 23.8% | -7.1% |
| Revenuesfromanticd20therapeuticprograms | $1.9B | $0 | 0.0% | 11.0% | +6.3% |
| SPINRAZA | $1.5B | $0 | 0.0% | 9.1% | -1.7% |
| Fumarate | $1.4B | $0 | 0.0% | 8.4% | -10.6% |
| Royalty Attributed To OCREVUS | $1.4B | $0 | 0.0% | 8.3% | +5.6% |
| Interferon | $946M | $0 | 0.0% | 5.6% | -2.3% |
| VUMERITY | $747M | $0 | 0.0% | 4.4% | +18.9% |
| Biosimilars | $729M | $0 | 0.0% | 4.3% | -8.1% |
| AVONEX | $696M | $0 | 0.0% | 4.1% | -1.7% |
| TECFIDERA | $680M | $0 | 0.0% | 4.0% | -29.7% |
| Contract Manufacturing And Other Revenue | $679M | $0 | 0.0% | 4.0% | +14.7% |
| SKYCLARYS | $521M | $0 | 0.0% | 3.1% | +36.1% |
| BENEPALI | $453M | $0 | 0.0% | 2.7% | -5.4% |
| PLEGRIDY | $250M | $0 | 0.0% | 1.5% | -4.0% |
| Other | $197M | $0 | 0.0% | 1.2% | +139.0% |
| ZURZUVAE | $195M | $0 | 0.0% | 1.1% | +170.2% |
| IMRALDI | $190M | $0 | 0.0% | 1.1% | -10.7% |
| Alzheimers Collaboration | $178M | $0 | 0.0% | 1.0% | +196.7% |
| QALSODY | $87M | $0 | 0.0% | 0.5% | +168.2% |
| Royalty | $54M | $0 | 0.0% | 0.3% | -11.6% |
| FLIXABI | $53M | $0 | 0.0% | 0.3% | -16.8% |
| BYOOVIZ | $32M | $0 | 0.0% | 0.2% | -11.5% |
| FUMADERMAnd ADUHELM | $2M | $0 | 0.0% | 0.0% | -79.6% |
| FAMPYRA | $1M | $0 | 0.0% | 0.0% | -98.0% |
| TOFIDENCE | $700,000 | $0 | 0.0% | 0.0% | -36.4% |
| Clinical Inventory | $0 | $0 | 0.0% | 0.0% | +0.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free